These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20978159)

  • 1. Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.
    Ichite N; Chougule M; Patel AR; Jackson T; Safe S; Singh M
    Mol Cancer Ther; 2010 Nov; 9(11):3003-14. PubMed ID: 20978159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.
    Andey T; Patel A; Jackson T; Safe S; Singh M
    Eur J Pharm Sci; 2013 Oct; 50(2):227-41. PubMed ID: 23892137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.
    Ichite N; Chougule MB; Jackson T; Fulzele SV; Safe S; Singh M
    Clin Cancer Res; 2009 Jan; 15(2):543-52. PubMed ID: 19147759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models.
    Coxon A; Ziegler B; Kaufman S; Xu M; Wang H; Weishuhn D; Schmidt J; Sweet H; Starnes C; Saffran D; Polverino A
    Mol Cancer; 2012 Sep; 11():70. PubMed ID: 22992329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Singh M
    Pharm Res; 2006 Sep; 23(9):2094-106. PubMed ID: 16902813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
    Lu Z; Wientjes TS; Au JL
    Pharm Res; 2005 Jul; 22(7):1069-78. PubMed ID: 16028007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.
    Patel AR; Godugu C; Wilson H; Safe S; Singh M
    Pharm Res; 2015 Jul; 32(7):2292-300. PubMed ID: 25576245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.
    Patel AR; Doddapaneni R; Andey T; Wilson H; Safe S; Singh M
    J Control Release; 2015 Sep; 213():18-26. PubMed ID: 26079185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
    Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
    Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
    Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer.
    Godugu C; Doddapaneni R; Safe SH; Singh M
    Eur J Pharm Biopharm; 2016 Nov; 108():168-179. PubMed ID: 27586082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
    Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
    Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.
    Patel AR; Chougule M; Singh M
    Pharm Res; 2014 Oct; 31(10):2796-809. PubMed ID: 24867421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
    Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
    Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
    Meng J; Dai B; Fang B; Bekele BN; Bornmann WG; Sun D; Peng Z; Herbst RS; Papadimitrakopoulou V; Minna JD; Peyton M; Roth JA
    PLoS One; 2010 Nov; 5(11):e14124. PubMed ID: 21124782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
    Tang N; Zhang Q; Fang S; Han X; Wang Z
    Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
    Lei P; Abdelrahim M; Cho SD; Liu S; Chintharlapalli S; Safe S
    Carcinogenesis; 2008 Jun; 29(6):1139-47. PubMed ID: 18460448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
    York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary diindolylmethane suppresses inflammation-driven lung squamous cell carcinoma in mice.
    Song JM; Qian X; Teferi F; Pan J; Wang Y; Kassie F
    Cancer Prev Res (Phila); 2015 Jan; 8(1):77-85. PubMed ID: 25403850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.